VKTX - Ligand's Shots On Goal Target (Podcast Transcript)
Editors' Note: This is the transcript version of the podcast we published yesterday on Ligand Pharmaceuticals (LGND). We hope you enjoy it.
Introduction
Daniel Shvartsman: This week on Behind The Idea we talk about Ligand Pharmaceuticals, ticker symbol, LGND. The company and the Seeking Alpha Author, who recently wrote about it, expound the shots on goal philosophy as a way to explain the company's business model and how it's a more diversified biotech pick. But it's also been the target of several short sellers over the year. So does this translate into a